Lactimidomycin

Lactimidomycin

Identifiers
IUPAC name 4-[(E,2R,5S)-2-hydroxy-5-methyl-7-[(2R,3S,4Z,6E,10E)-3-methyl-12-oxo-1-oxacyclododeca-4,6,10-trien-2-yl]-4-oxooct-6-enyl]piperidine-2,6-dione
CAS Number	134869-15-1  Y
PubChem CID	11669726
ChemSpider	9844457
ChEMBL	ChEMBL1221911
Chemical and physical data
Formula	C26H35NO6
Molar mass	457.567 g·mol−1
3D model (JSmol)	Interactive image
SMILES N2C(=O)CC(CC2=O)CC(O)CC(=O)C(C)\C=C(/C)\C1OC(=O)C=CCCC=CC=CC1C
InChI InChI=1S/C26H35NO6/c1-17-10-8-6-4-5-7-9-11-25(32)33-26(17)19(3)12-18(2)22(29)16-21(28)13-20-14-23(30)27-24(31)15-20/h4,6,8-12,17-18,20-21,26,28H,5,7,13-16H2,1-3H3,(H,27,30,31)/b6-4+,10-8-,11-9+,19-12+/t17-,18-,21+,26+/m0/s1 Key:OYOKHBHOTQDIPM-BRHOHSSQSA-N

Lactimidomycin is a glutarimide antibiotic derived from the bacteria Streptomyces amphibiosporus. ^{[1] [2]} It has antifungal, antiviral and anti-cancer properties, acting as a direct inhibitor of protein translation in ribosomes. ^{[3] [4] [5]} Antiviral activity is seen against a variety of RNA viruses including flaviviruses such as dengue fever, Kunjin virus and Modoc virus, as well as vesicular stomatitis virus and poliovirus. ^[6] As lactimidomycin is a natural product containing an unusual unsaturated 12-membered lactone ring, it has been the subject of numerous total synthesis approaches. ^{[7] [8] [9] [10]}

References

1. Sugawara K, Nishiyama Y, Toda S, Komiyama N, Hatori M, Moriyama T, et al. (September 1992). "Lactimidomycin, a new glutarimide group antibiotic. Production, isolation, structure and biological activity". The Journal of Antibiotics. 45 (9): 1433–41. doi: 10.7164/antibiotics.45.1433 . PMID   1429229.
2. Ju J, Seo JW, Her Y, Lim SK, Shen B (December 2007). "New lactimidomycin congeners shed insight into lactimidomycin biosynthesis in Streptomyces amphibiosporus". Organic Letters. 9 (25): 5183–6. doi:10.1021/ol702249g. PMID   17997563.
3. Schneider-Poetsch T, Ju J, Eyler DE, Dang Y, Bhat S, Merrick WC, et al. (March 2010). "Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin". Nature Chemical Biology. 6 (3): 209–217. doi:10.1038/nchembio.304. PMC   2831214 . PMID   20118940.
4. Micoine K, Persich P, Llaveria J, Lam MH, Maderna A, Loganzo F, Fürstner A (June 2013). "Total syntheses and biological reassessment of lactimidomycin, isomigrastatin and congener glutarimide antibiotics". Chemistry: A European Journal. 19 (23): 7370–83. doi:10.1002/chem.201300393. PMID   23595541.
5. Garreau de Loubresse N, Prokhorova I, Holtkamp W, Rodnina MV, Yusupova G, Yusupov M (September 2014). "Structural basis for the inhibition of the eukaryotic ribosome". Nature. 513 (7519): 517–22. Bibcode:2014Natur.513..517G. doi:10.1038/nature13737. hdl: 11858/00-001M-0000-0023-EE38-0 . PMID   25209664. S2CID   4460881.
6. Carocci M, Yang PL (April 2016). "Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses". Antiviral Research. 128: 57–62. doi:10.1016/j.antiviral.2016.02.005. PMC   4850914 . PMID   26872864.
7. Micoine K, Fürstner A (October 2010). "Concise total synthesis of the potent translation and cell migration inhibitor lactimidomycin". Journal of the American Chemical Society. 132 (40): 14064–6. Bibcode:2010JAChS.13214064M. doi:10.1021/ja107141p. PMID   20831202.
8. Larsen BJ, Sun Z, Nagorny P (June 2013). "Synthesis of eukaryotic translation elongation inhibitor lactimidomycin via Zn(II)-mediated Horner-Wadsworth-Emmons macrocyclization". Organic Letters. 15 (12): 2998–3001. doi:10.1021/ol401186f. PMID   23731327.
9. Nagasawa T, Kuwahara S (June 2013). "Formal total synthesis of lactimidomycin". Organic Letters. 15 (12): 3002–5. doi:10.1021/ol401214f. PMID   23731346.
10. Larsen BJ, Sun Z, Lachacz E, Khomutnyk Y, Soellner MB, Nagorny P (December 2015). "Synthesis and Biological Evaluation of Lactimidomycin and Its Analogues". Chemistry: A European Journal. 21 (52): 19159–67. doi:10.1002/chem.201503527. PMID   26577990.